Brief: Cutera Provides Response To FDA Inquiry

Cutera

01/12/2022 21:58

Dec 1 (Reuters) - Cutera Inc  CUTR.O :
    * CUTERA PROVIDES RESPONSE TO FDA INQUIRY
    * FDA RECENTLY ISSUED A WARNING LETTER TO CUTERA IDENTIFYING
A
VESTIGIAL PIECE OF MARKETING MATERIAL THAT HAD ESCAPED CUTERA'S
ATTENTION
    * WEBSITE THAT WAS REGISTERED TO CUTERA, BUT HOSTED &
MANAGED BY
NON-U.S. THIRD PARTY ON CUTERA'S BEHALF, WAS MISTAKENLY NOT
TAKEN DOWN IN 2019
    * BELIEVES INCIDENT REGARDING MYJULIET WAS AN ISOLATED
OVERSIGHT
AND IS TAKING ACTION TO PREVENT ANY SUCH RECURRENCE
    * SITE IDENTIFIED BY FDA IS NO LONGER ACTIVE

Source text for Eikon:  ID:nBw7mSYsza 
Further company coverage:  CUTR.O 
 ((Reuters.Briefs@thomsonreuters.com))